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a  b  s  t  r  a  c  t
Alkaptonuria is a rare metabolic disease in which a deﬁciency of the enzyme homogentisate
dioxygenase  causes an accumulation of homogentisic acid. Ochronosis consists of exces-
sive  deposition of homogentisic acid in the connective tissue and presents as a chestnut
brown  or black pigmentation. With aging, the accumulation of pigments from homogentisic
acid  in the joints causes osteoarthrosis. There is no speciﬁc treatment for the disease and
the  approach is symptomatic. Arthroplasty is the solution for severe cases of osteoarthro-
sis  caused by this pathological condition and presents results comparable to those from
patients  with primary osteoarthrosis. Here, the case of a 67-year-old patient who underwent
several  arthroplasty procedures because of osteoarthrosis caused by this rare pathological
condition  is presented. The last surgical intervention consisted of total right knee arthro-
plasty.
©  2014 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora
Ltda. 
Osteoartrose  do  joelho  secundária  a ocronose  –  Caso  clínico
alavras-chave:
r  e  s  u  m  o
A alcaptonúria é uma doenc¸a  metabólica rara em que a deﬁciência da enzima ácido
Este é um artigo Open Access sob a licença de CC BY-NC-NDlcaptonúria homogentísico-oxidase provoca uma acumulac¸ão  de ácido homogentísico. A ocronose con-
xcessiva de ácido homogentísico no tecido conjuntivo e apresenta-secronose siste  na deposic¸ão  e
oelho
rtroplastia
como  uma pigmentac¸ão  acastanhada ou preta. Com o envelhecimento, a acumulac¸ão  de
pigmentos  de ácido homogentísico nas articulac¸ões  provoca osteoartrose. Não existe um
tratamento  especíﬁco para a doenc¸a  e a abordagem é sintomática. A artroplastia é a soluc¸ão
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para casos graves de osteoartrose causada por essa patologia e apresenta resultados com-
paráveis aos doentes com osteoartrose primária. Os autores apresentam o caso de um
doente de 67 anos submetido a várias artroplastias, em virtude da osteoartrose causada
por essa rara patologia. A última intervenc¸ão  cirúrgica foi uma artroplastia total do joelho
direito.
©  2014 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por Elsevier
Editora Ltda. 
affected the left hip, followed by the left knee and lastly the
Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Alkaptonuria is a rare recessive autosomal metabolic disease
caused  by absence of the enzyme homogentisic oxidase. This
enzyme  is responsible for degradation of homogentisic acid,
which  is an intermediate product from metabolism of the
amino  acids tyrosine and phenylalanine. If this enzyme is
defective,  this leads to accumulation of homogentisic acid in
tissues and blood.
The  incidence of alkaptonuria is less than one in one
million.1
Over time, the deposits of homogentisic acid accumulate
in  the tissues and present as a dark pigmentation. This con-
dition  is called ochronosis and it may  affect not only the
musculoskeletal system but also the cardiovascular and gen-
itourinary  systems, the sclera and the skin.2,3
Most of the symptoms of alkaptonuria are only observed
starting in the fourth or ﬁfth decade of life,4 except for the
appearance of dark urine, which is detected during childhood,
resulting from excretion and oxidation of homogentisic acid.
Alkaptonuria  causes progressive ochronotic arthropathy
of  the major joints that are subject to weight-bearing. The
Fig. 1 – Dark pigment in the sclera, ears and ﬁrst interdigital crea
darkened appearance of the urine.knee is the joint that is most affected, followed by the
hip.4–6
The treatment for the disease is symptomatic and total
arthroplasty is the preferred treatment in severe cases of
osteoarthrosis.7,8
Clinical  case
The patient was a 67-year-old man  whose diagnosis of alkap-
tonuria  had been made at the age of 40 years. The ﬁrst signs
of  the disease were  darkening of the urine and appearance of
dark  pigments in the sclera, ears and ﬁrst interdigital crease
of  the left hand (Fig. 1A–D). There were no other relevant
antecedents or any family history of the disease.
At the age of 60 years, the patient underwent a surgical
intervention to extract a bladder stone of large dimensions
(Fig.  2).
Joint complaints arose some years later and initiallyse of the left hand. The last ﬁgure demonstrates the
right  knee.
The  patient was referred for an orthopedics consultation
and the ﬁrst surgical intervention was  total arthroplasty of the
r e v b r a s o r t o p . 2 0 1 4
l
a
w
t
t
p
s
a
o
k
i
t
i
kFig. 2 – Bladder stone.
eft hip, performed ﬁve years before the present case (Fig. 3A
nd  B).
Twelve months before the present case, the patient under-
ent  total arthroplasty of the left knee (Fig. 4A–C). Both of
hese  surgical procedures were  performed at another hospi-
al  institution. So far, there have not been any mentions of
ostoperative complications.
At  the consultation of the present case, the patient pre-
ented  complaints of pain in his right knee, with a varus knee
nd  radiologically observed three-compartment gonarthrosis
f  Ahlbäck grade IV (Fig. 4A and B).
The patient underwent total arthroplasty of the right
nee  (Fig. 5A and B) at our hospital. The complaints of pain
mproved  immediately after the operation.
After six months of follow-up, the patient is now asymp-
omatic and able to walk without gait supports. His mobility
◦ ◦ ◦ ◦s  from 0 to 110 in the right knee and 0 to 120 in the left
nee.  He continues to be followed up as an outpatient.
Fig. 3 – Cemented total hip arthroplasty perfo;4 9(6):675–680  677
Discussion
Alkaptonuria was  ﬁrst described in 1584, in children with dark
urine.
At  the end of the 1990s, it was observed that the gene
for  this pathological condition was  present at the locus 3q21-
23.9
Ochronosis consists of deposition of pigments from
homogentisic acid in all types of connective tissue and par-
ticularly  in cartilage. It mainly affects the musculoskeletal
system, but can also affect the cardiovascular and genitouri-
nary  systems, the sclera and the skin.2,3
The ﬁrst clinical manifestation of alkaptonuria is the
appearance of dark urine.10 Other alterations that are often
neglected include changes to the color of the sclera and ears.
These  signs could also be identiﬁed in our patient.
Ochronotic arthropathy fundamentally affects individuals
from  the age of 40 years onwards, as seen in the case pre-
sented  here. The pain complaints affect the major joints and
especially  the knees, followed by the hips, shoulders, spine
and  even the ribs.11 In our case, the ﬁrst joint to be affected
was  the left hip.
The  pigmentation also affects the tendons and ligaments,
because of their high collagen content, and it causes inﬂam-
matory  alterations that may  lead to tearing.7
Like in patients with primary osteoarthrosis, narrowing of
the  interline and sclerosis of the joint space are frequently
seen. However, the radiological alterations may  be much  less
exuberant  than the clinical manifestations.
Macroscopically, patients affected by ochronosis present
small  particles resembling soot, encrusted in the menisci,
tendons and ligaments, which confers the typical dark col-
oration  of the joints. This could be seen in the intraoperative
images of the present case (Fig. 6A–C). The anatomopatholog-
ical examination on the operative specimens conﬁrmed the
diagnosis.There  is no speciﬁc medical treatment for alkaptonuria
and therefore the therapeutic approach is symptomatic. In
rmed ﬁve years before the present case.
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Fig. 4 – Total arthroplasty of the left knee performed 12 months before the present case. Right knee with three-compartment
gonarthrosis of Ahlbäck grade IV.
Fig. 5 – Radiograph of the knees with weight-bearing and lateral view of the right knee six months after total arthroplasty.
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Fig. 6 – Intraoperative images documenting the typical dark coloration of the joint that resulted from deposition of pigments
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evere cases of osteoarthrosis, total arthroplasty is the pre-
erred  treatment.7,8
Few studies have reported the mechanical differences that
ay  occur in the bone and soft tissues of patients who undergo
rthroplasty, or the complications during the operation or
ostoperative follow-up.
In  patients undergoing total knee arthroplasty, Spencer
t  al.12 were  faced with intraoperative difﬁculties in displacing
he  patella, because the quadriceps and patellar tendons were
xtremely  hard. Although we  did not have this difﬁculty, we
bserved  during the operation that both the hips presented an
nusually hard consistency.
In  the same study, no complications relating to implant
ailure were  detected in patients with ochronosis who under-
ent  total arthroplasty on different joints, with 12 years
f  follow-up. Other studies have presented results compat-
ble  with performing arthroplasty in patients with primary
steoarthrosis.13–15
Early treatment for alkaptonuria may  be a challenge, given
hat  the approach is symptomatic.
Cases  of ochronotic arthrosis that are more advanced
equire surgical treatment.As  already reported total knee arthroplasty presents good
esults  in patients with gonarthrosis secondary to this rare
athological condition.nd ligaments.
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